Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
  1. 10-Q Report Quarterly Report
  2. 8-K Event Executive or director change
  3. 8-K Event Executive or director change
  4. 4 Option exercise Chief Medical Officer acquired 27,229 shares (option exercise)
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Shareholder vote results
  15. 10-Q Report Quarterly Report
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. 8-K Event Regulation FD disclosure
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 15 of 20 · 400 filings